Ad hoc announcement according to article 53 KR
HOCHDORF Holding Ltd: Amir Mechria converts part of Mandatory Convertible Bond
Fractional conversion of mandatory convertible bond
Hochdorf
(pta006/04.11.2019/07:00 UTC+1)
As of today, Amir Mechria will convert three quarters of his stake in the 2017-2020 mandatory convertible bond of HOCHDORF Holding Ltd with a nominal value of CHF 98.25 million. 322,480 shares of HOCHDORF Holding Ltd will thus be allocated to him. This transaction increases the number of outstanding shares of HOCHDORF Holding Ltd to 1,758,369. At the same time, Amir Mechria will become the largest shareholder of the HOCHDORF Group with 18.34%. The voting rights of the HOCHDORF Group are limited to 15% in accordance with the statutes.
At the end of 2016, Amir Mechria sold 51% of Pharmalys Laboratories SA to the HOCHDORF Group. Mechria still holds a 49% stake in Pharmalys Laboratories SA.
(end)
Emitter: |
HOCHDORF Holding Ltd Siedereistrasse 9 6281 Hochdorf Switzerland |
|
---|---|---|
Contact Person: | Dr. Christoph Hug | |
Phone: | +41 41 914 65 62 | |
E-Mail: | christoph.hug@hochdorf.com | |
Website: | www.hochdorf.com/ | |
ISIN(s): | CH0024666528 (Share) | |
Stock Exchange(s): | SIX Swiss Exchange |